ARRY — ARRAY BIOPHARMA INC

Ownership history in Squarepoint Ops LLC  ·  54 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in ARRAY BIOPHARMA INC (ARRY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2020 Q4)
Avg. % of fund
0.01%
First filed
2015 Q4
Last filed
2025 Q3
Quarters held
54
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 51,300 -404,069 -88.7% 0.00% $418K $8.15
2025 Q3 ADDED 455,369 +304,669 +202.2% 0.00% $3.7M $8.15
2025 Q3 REDUCED 150,700 -381,222 -71.7% 0.00% $1.2M $8.15
2025 Q2 ADDED 531,922 +380,922 +252.3% 0.00% $3.1M $5.90
50 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ARRY price (monthly, adj. close)

Other funds also holding ARRY

As of 2025 Q4 — sorted by position size

USCF Advisers LLC 6.13% DECADE RENEWABLE PARTNERS LP 3Y 4.71% Hill City Capital, LP 3Y 4.49% Redwood Grove Capital, LLC 3Y 4.34% Goodlander Investment Management, LLC 3.87% Villanova Investment Management Co LLC 1.22% Electron Capital Partners, LLC 3Y 7Y 1.13% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.56% Green Alpha Advisors, LLC 3Y 0.49% SILVERBACK ASSET MANAGEMENT LLC 3Y 7Y 0.4%
← Back to Squarepoint Ops LLC Holdings